Literature DB >> 12654515

VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death.

Baolin Li1, Wei Xu, Chun Luo, David Gozal, Rugao Liu.   

Abstract

The increased oxidative stress induced by mutant SOD1 is associated with motor neuron degeneration in both human ALS and transgenic mice expressing mutant SOD1. Vascular endothelial growth factor (VEGF) is neurotrophic and also protects from hypoxia-induced neuronal injury. The potential role of VEGF in preventing mutant SOD1-mediated motor neuron cell death was examined using a mouse NSC34 motor neuron-like cell culture system. Infection with adenovirus containing mutant G93A-SOD1, but not vector control or wild-type SOD1, increased cellular oxidative stress and motor neuron-like cell death. However, NSC34 cells pretreated with VEGF displayed a dose-dependent resistance to oxidative damage from hydrogen peroxide, TNF-alpha, and mutant G93A-SOD1. VEGF activated both PI3-K and MAPK activities in mouse NSC34 motor neuron-like cells. Pharmacological inhibitors and constitutively active as well as dominant negative mutants of MAPK and PI3-K revealed that the protective effects of VEGF were mediated via the PI3-K activity, and that MAPK activation was not associated with NSC34 cell survival. Furthermore, VEGF-induced downstream Akt activation promoted motor neuron-like NSC34 cell survival in the presence of mutant G93A-SOD1. Thus, VEGF protected mouse NSC34 motor neuron-like cell death from mutant G93A-SOD1 effects via PI3-K/Akt activation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654515     DOI: 10.1016/s0169-328x(03)00025-1

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  40 in total

1.  Vascular endothelial growth factor protects post-ganglionic sympathetic neurones from the detrimental effects of hydrogen peroxide by increasing catalase.

Authors:  D H Damon
Journal:  Acta Physiol (Oxf)       Date:  2011-03-14       Impact factor: 6.311

Review 2.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

3.  Expression of pERK and pAKT in human astrocytomas: correlation with IDH1-R132H presence, vascular endothelial growth factor, microvascular characteristics and clinical outcome.

Authors:  Angelica A Saetta; Georgia Levidou; Elias A El-Habr; Ioannis Panayotidis; Vassilis Samaras; Irene Thymara; Stratigoula Sakellariou; Efstathios Boviatsis; Efstratios Patsouris; Penelope Korkolopoulou
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

Review 4.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

5.  Prokineticin 2 is an endangering mediator of cerebral ischemic injury.

Authors:  Michelle Y Cheng; Alex G Lee; Collin Culbertson; Guohua Sun; Rushi K Talati; Nathan C Manley; Xiaohan Li; Heng Zhao; David M Lyons; Qun-Yong Zhou; Gary K Steinberg; Robert M Sapolsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

6.  Endothelin-1 Induces Degeneration of Cultured Motor Neurons Through a Mechanism Mediated by Nitric Oxide and PI3K/Akt Pathway.

Authors:  S D'Antoni; E Ranno; M Spatuzza; S Cavallaro; M V Catania
Journal:  Neurotox Res       Date:  2017-03-11       Impact factor: 3.911

Review 7.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

8.  The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.

Authors:  Min Young Noh; Young Seo Kim; Kyu-Yong Lee; Young Joo Lee; Seung H Kim; Hyun-Jeung Yu; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2012-12-20       Impact factor: 5.590

9.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

Review 10.  Vascular endothelial growth factor: a neurovascular target in neurological diseases.

Authors:  Christian Lange; Erik Storkebaum; Carmen Ruiz de Almodóvar; Mieke Dewerchin; Peter Carmeliet
Journal:  Nat Rev Neurol       Date:  2016-07-01       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.